Enzolytics’ IPF Immune™ Supports the Body’s Self-Defense System
Industry: Health & Fitness
IPF Immune™ Plans U.S. Product Launch
Boca Raton, FL (PRUnderground) November 8th, 2022
IPF Immune™, a dietary supplement that supports the immune system, will soon be available to consumers in the U.S.
“We will soon launch IPF Immune™, an over-the-counter liquid dietary supplement,” said Charles S. Cotropia, CEO of Enzolytics, Inc. “We have met with buyers from some of the most sought-after retailers in the country. We are working to add retail outlets to make it easy for consumers to find IPF Immune™.”
Here are some facts about the dietary supplement industry:
- The average American spends almost $100 per trip on vitamins and supplements.
- The U.S. vitamin and supplement industry currently totals $35.6 billion in 2022 while the global sector is worth $151.9 billion.
- Older Americans from the Greatest Generation and Baby Boomers spend the most per purchase on dietary supplements, $129.58 and $111.59, respectively. Gen X totals $82.06 and Millennials are at $62.73.
“It is obvious that Americans take vitamins and supplements for health reasons,” Mr. Cotropia said. “Dietary supplement usage has been increasing for years, but the pandemic forced everyone to focus on their health.”
During the health crisis, Mr. Cotropia said consumers started searching for vitamins and supplements that would support their immune systems.
Enzolytics IPF Immune™, which is gluten-free, is a nutritional supplement that is taken orally two consecutive days per week for eight consecutive weeks.
“In the coming months, we will be working hard promoting IPF Immune™ to consumers and retailers,” Mr. Cotropia said. “Retailers know consumer interest in dietary supplements has been increasing.
“Consumers want to take a proactive approach to their health, which is why they are turning to dietary supplements,” he added. “Retailers are taking note of this trend.”
For more information, email firstname.lastname@example.org or visit enzolytics.com.
Disclaimer: The statements made regarding these products have not been evaluated by the Food and Drug Administration. This press release is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please check with your doctor. The news site hosting this press release is not associated with Enzolytics, Inc. It is merely publishing a press release announcement submitted by a company, without any stated or implied endorsement of the product or service.
SOURCE: Enzolytics, Inc.
About Enzolytics, Inc.
Enzolytics Inc. is a Texas-based biotechnology company that focuses on therapeutics to treat numerous human health medical conditions. In addition to Enzolytics IPF Immune™, which will be on the U.S. market soon, the Company is developing other therapeutics for treating multiple infectious diseases.